InsiderTrades

Form 4 for LLY Lilly (Eli)

Accepted 2026-02-11 00:00:00 ET · period of report 2026-02-09 · accession 0001561539-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-11 2026-02-09 LLY Zakrowski Donald A SVP, CAO, Fin A - Grant $1,044.67 +583.78 3,423 +21% +$609.9K
D 2026-02-11 2026-02-09 LLY Zakrowski Donald A SVP, CAO, Fin A - Grant $0.00 +199.47 199.47 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-09 A A 583.78 $1,044.67 3,423.44 D — —
2 Derivative Restricted Stock Unit 2026-02-09 A A 199.47 $0.00 199.47 D — · 2029-02-16 to 2029-02-16 199.47 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.